MAP2K7 and neoplasm: Notably, in these experiments, neither of the single drug treatments resulted in significant tumor growth reduction; however, the combination of MEK and CENPE inhibitors synergistically and significantly reduced tumor volume (p < 0.01, t-test) after 4 weeks of treatment in vivo (Fig. 3i).